Compounds > lysine
Page last updated: 2024-08-17

lysine and ER-Negative PR-Negative HER2-Negative Breast Cancer

lysine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (27.27)24.3611
2020's8 (72.73)2.80

Authors

AuthorsStudies
Gao, Y; He, X; Liu, H; Liu, J; Qian, X; Wang, R; Zhao, K1
Baudre, L; Baulande, S; Bento, ST; Bohec, M; Dahmani, A; Durand, A; Eisele, A; Foulon, S; Grosselin, K; Landragin, C; Letouzé, E; Lyne, AM; Marangoni, E; Marsolier, J; Perié, L; Prompsy, P; Salomon, AV; Sourd, L; Trouchet, A; Vallot, C1
Ding, Y; Fu, M; Gao, H; Li, X; Li, Z; Su, P; Wang, D; Xia, Y; Yang, H; Yang, X; Zhang, C; Zhang, Y; Zhu, J; Zhuang, T; Zhuo, S1
Chen, XL; Ren, YX; Ren, ZF; Shi, YY; Tang, LY; Wang, B; Yang, YZ; Zhou, M1
Batbayar, G; Horike, SI; Ishimura, A; Lyu, H; Meguro-Horike, M; Suzuki, T; Takino, T; Terashima, M; Wanna-Udom, S1
Chen, Y; Gao, L; He, Y; Kong, X; Li, G; Li, Q; Li, Y; Liu, Y; Long, Q; Pu, P; Tong, S; Yang, Y; Zhang, J1
Andreu, D; Arribas, J; Bernado-Morales, C; Cebrià-Costa, JP; Cigliano, RA; Cosín, M; de Herreros, AG; Gonzalez-Perez, A; Iturbide, A; Nuciforo, P; Pascual-Reguant, L; Peiró, S; Querol, J; Rodilla, V; Sanseverino, W; Segura-Bayona, S; Serra-Bardenys, G; Stracker, TH; Verde, G; Yelamos, J1
Castro-Piedras, I; Martinez, EG; Molehin, D; Pruitt, K; Sharma, M1
Chepikova, OE; Cryns, VL; Lukasheva, EV; Malin, D; Strekalova, E; Zamyatnin, AA1
Fan, J; Feng, G; Han, J; Jiang, L; Jiang, X; Kou, X; Lin, Z; Liu, H; Sun, F; Wang, X; Yang, Y1
Fan, H; Feng, J; Li, J; Liu, C; Meng, Z; Peng, Y; Wang, L; Yuan, L; Zhao, W; Zheng, Q1

Other Studies

11 other study(ies) available for lysine and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
SENP1 promotes triple-negative breast cancer invasion and metastasis via enhancing CSN5 transcription mediated by GATA1 deSUMOylation.
    International journal of biological sciences, 2022, Volume: 18, Issue:5

    Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; COP9 Signalosome Complex; Cysteine Endopeptidases; GATA1 Transcription Factor; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Lysine; Peptide Hydrolases; Triple Negative Breast Neoplasms; Tumor Microenvironment

2022
H3K27me3 conditions chemotolerance in triple-negative breast cancer.
    Nature genetics, 2022, Volume: 54, Issue:4

    Topics: Drug Resistance, Neoplasm; Histones; Humans; Lysine; Methylation; Neoplasm Recurrence, Local; Triple Negative Breast Neoplasms

2022
RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis.
    Cell communication and signaling : CCS, 2022, 10-24, Volume: 20, Issue:1

    Topics: Cell Line, Tumor; Cell Proliferation; Estrogen Receptor alpha; Humans; Lysine; RNA, Messenger; Transcription Factors; Triple Negative Breast Neoplasms; Ubiquitin-Protein Ligases; Ubiquitins

2022
Survival is associated with repressive histone trimethylation markers in both HR-positive HER2-negative and triple-negative breast cancer patients.
    Virchows Archiv : an international journal of pathology, 2023, Volume: 482, Issue:6

    Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Histones; Humans; Lysine; Proportional Hazards Models; Receptor, ErbB-2; Receptors, Progesterone; Triple Negative Breast Neoplasms

2023
ASH2L, a COMPASS core subunit, is involved in the cell invasion and migration of triple-negative breast cancer cells through the epigenetic control of histone H3 lysine 4 methylation.
    Biochemical and biophysical research communications, 2023, 08-20, Volume: 669

    Topics: DNA-Binding Proteins; Epigenesis, Genetic; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation; Nuclear Proteins; Transcription Factors; Triple Negative Breast Neoplasms

2023
SETD7 promotes metastasis of triple-negative breast cancer by YY1 lysine methylation.
    Biochimica et biophysica acta. Molecular basis of disease, 2023, Volume: 1869, Issue:7

    Topics: Cell Proliferation; Female; Histone-Lysine N-Methyltransferase; Humans; Lysine; Methylation; Protein Processing, Post-Translational; Triple Negative Breast Neoplasms; YY1 Transcription Factor

2023
LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells.
    Oncogene, 2020, Volume: 39, Issue:1

    Topics: Amino Acid Oxidoreductases; Animals; Cell Line, Tumor; Chromatin; DNA Damage; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Heterochromatin; Heterografts; Histone Code; Histones; Humans; Lysine; Mice; Oxidation-Reduction; Triple Negative Breast Neoplasms

2020
Acetylation of conserved DVL-1 lysines regulates its nuclear translocation and binding to gene promoters in triple-negative breast cancer.
    Scientific reports, 2019, 11-07, Volume: 9, Issue:1

    Topics: Acetylation; Amino Acid Sequence; Aromatase; Biomarkers; Cell Line, Tumor; Cell Nucleus; Dishevelled Proteins; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Lysine; Models, Biological; Oxygen; Promoter Regions, Genetic; Protein Binding; Protein Interaction Domains and Motifs; Protein Processing, Post-Translational; Protein Transport; Triple Negative Breast Neoplasms

2019
Lysine oxidase exposes a dependency on the thioredoxin antioxidant pathway in triple-negative breast cancer cells.
    Breast cancer research and treatment, 2020, Volume: 183, Issue:3

    Topics: Antioxidants; Humans; Lysine; Oxidative Stress; Oxidoreductases; Reactive Oxygen Species; Thioredoxins; Triple Negative Breast Neoplasms

2020
Simvastatin functions as a heat shock protein 90 inhibitor against triple-negative breast cancer.
    Cancer science, 2018, Volume: 109, Issue:10

    Topics: Acetylation; Adenosine Triphosphate; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Chaperonins; Female; HSP90 Heat-Shock Proteins; Humans; Hydroxamic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lysine; Mice; Mice, Inbred BALB C; Mice, Nude; Panobinostat; Protein Binding; Simvastatin; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2018
Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription.
    Acta biochimica et biophysica Sinica, 2018, Sep-01, Volume: 50, Issue:9

    Topics: Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p57; F-Box Proteins; Gene Expression Regulation, Neoplastic; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Methylation; Promoter Regions, Genetic; Protein Binding; RNA Interference; Triple Negative Breast Neoplasms

2018